{"contentid": 488663, "importid": NaN, "name": "European pharma industry calls for strategic reform to stay competitive", "introduction": "Medicines for Europe, the trade group representing the generics and biosimilars industry in Europe, has welcomed an update to the 2020 industrial strategy published by the European Commission (EC).", "content": "<p><span style=\"font-weight: 400;\">Medicines for Europe, the trade group representing the generics and biosimilars industry in Europe, has welcomed an</span> <a href=\"https://ec.europa.eu/commission/presscorner/detail/en/IP_21_1884\"><span style=\"font-weight: 400;\">update to the 2020 industrial strategy</span></a><span style=\"font-weight: 400;\"> published by the European Commission (EC).</span></p>\n<p><span style=\"font-weight: 400;\">Against a backdrop of challenges presented by the ongoing coronavirus pandemic, the EC is seeking to support Europe&rsquo;s recovery and boost open strategic manufacturing in the region.</span></p>\n<p><span style=\"font-weight: 400;\">Medicines for Europe members supply and manufacture the majority of medicines for emergency care, infectious diseases, chronic care, oncology and more.</span></p>\n<p><span style=\"font-weight: 400;\">While Europe remains a major global manufacturer of active pharmaceutical ingredients, burgeoning manufacturing hubs in India and China are growing at a much faster rate, with governments there also pursuing robust industrial strategies.</span></p>\n<p><span style=\"font-weight: 400;\">Medicines for Europe has called on authorities to encourage an expansion of medicines production, with a &ldquo;smart industrial strategy for pharmaceutical production.&rdquo;</span></p>\n<p><span style=\"font-weight: 400;\">This would include coordination with relevant stakeholders, identifying the strengths and weaknesses of pharmaceutical supply chains while proposing policy reforms to encourage investments in manufacturing.</span></p>\n<p><span style=\"font-weight: 400;\">The group also wants so-called &ldquo;smart&rdquo; policies which move away from cost-containment reimbursement measures and procurement policies which &ldquo;look beyond the lowest price only.&rdquo;</span></p>\n<p><span style=\"font-weight: 400;\">In addition, Medicines for Europe has called for digital transformation in the regulatory network, making medicine agencies interconnected to improve efficiency, helping prevent shortages and over-consolidation.</span></p>\n<p><span style=\"font-weight: 400;\">Trade group president Christoph Stoller said it was &ldquo;painful to see Europe gradually losing its essential pharmaceutical production.&rdquo;</span></p>\n<p><span style=\"font-weight: 400;\">He added: &ldquo;The EU industrial strategy published last week is an important first step to slow this process but tailored actions for the healthcare industry are needed.&rdquo;</span></p>", "date": "2021-05-18 16:43:00", "meta_title": NaN, "meta_keywords": "Europe, medicines, industrial, industry, strategy, European, pharmaceutical, group, published, manufacturing, production, strategic, update, trade, welcome", "meta_description": "Medicines for Europe, the trade group representing the generics and biosimilars industry in Europe, has welcomed an update to the 2020 industrial strategy publi", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-18 16:21:22", "updated": "2021-05-18 16:46:24", "access": NaN, "url": "https://www.thepharmaletter.com/article/european-pharma-industry-calls-for-strategic-reform-to-stay-competitive", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "europe_flag_eu_big.jpg", "image2id": "europe_flag_eu_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biosimilars, Generics", "therapy area_tag": "Cardio-vascular, Infectious diseases, Oncology, Respiratory and Pulmonary", "topic_tag": "Focus On, Government Affairs, Production, Regulation", "geography_tag": "Europe", "company_tag": "Medicines for Europe", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-18 16:43:00"}